Literature DB >> 9674667

Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. Uganda-Case Western Reserve University Research Collaboration.

V Pekovic1, H Mayanja, M Vjecha, J Johnson, A Okwera, P Nsubuga, R Mugerwa, J Ellner, C Whalen.   

Abstract

Compliance with tuberculosis preventive therapy in a randomized placebo-controlled trial in 2736 HIV-infected Ugandans was measured using urinary isoniazid metabolite testing, clinic attendance, and self-report. Overall, 77% of urine tests were positive, subjects kept 85% of their scheduled visits while on therapy, and 69% reportedly never forgot to take their medication. Different strategies were used for constructing three composite compliance indices in active arms: (1) an unweighted index of the summed scores on scaled compliance measures; (2) a weighted index using weights obtained from a survey of experts on tuberculosis; and (3) a statistically weighted index using principal components analysis. Composite indices were evaluated for reliability, validity, and practical utility. Understanding of the regimen, study arm, subsequent follow-up, tuberculosis status, and urine spot-check result were associated with composite compliance scores. The unweighted index in this study performed as well as the weighted indices.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674667     DOI: 10.1016/s0895-4356(98)00033-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

Review 1.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

2.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

Review 3.  Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy.

Authors:  Jeffrey S Barrett; Line Labbé; Marc Pfister
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

4.  Current practice and perception of screening for medication adherence in inflammatory bowel disease.

Authors:  Arvind J Trindade; Donald E Morisky; Adam C Ehrlich; Andrew Tinsley; Thomas A Ullman
Journal:  J Clin Gastroenterol       Date:  2011 Nov-Dec       Impact factor: 3.062

5.  Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana.

Authors:  Deborah A Gust; Barudi Mosimaneotsile; Unami Mathebula; Balladiah Chingapane; Zaneta Gaul; Sherri L Pals; Taraz Samandari
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

6.  Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.

Authors:  Tom A Szakacs; Douglas Wilson; D William Cameron; Michael Clark; Paul Kocheleff; F James Muller; Anne E McCarthy
Journal:  BMC Infect Dis       Date:  2006-06-13       Impact factor: 3.090

7.  Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study.

Authors:  Mesele Mindachew; Amare Deribew; Peter Memiah; Sibhatu Biadgilign
Journal:  Pan Afr Med J       Date:  2014-01-17

8.  Predictors of recurrent TB in sputum smear and culture positive adults: a prospective cohort study.

Authors:  Grace Muzanyi; Y Mulumba; Paul Mubiri; Harriet Mayanja; John L Johnson; Ezekiel Mupere
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.